TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
Holding TCRX?
Track your performance easily

TScan Therapeutics (TCRX) Balance Sheet

175 Followers

TScan Therapeutics Balance Sheet

TScan Therapeutics's total assets for Q2 2024 were $374.87M, an increase of 55.66% from the previous quarter. TCRX total liabilities were $119.65M for the fiscal quarter, a 1.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 272.15M$ 199.09M$ 188.11M$ 49.74M$ 49.38M
Total Liabilities
$ 121.28M$ 99.66M$ 27.33M$ 92.20M$ 66.52M
Total Equity Gross Minority
$ 150.87M$ 99.43M$ 160.78M$ -42.46M$ -17.14M
Total Capitalization
$ 263.41M$ 211.03M$ 160.78M$ -42.46M$ -17.14M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 7.43M$ 4.89M
Currency in USD

TScan Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis